[1]李纪伟.两种药品使用政策对门诊基本药物使用的影响[J].医学信息,2019,(19):124-126.[doi:10.3969/j.issn.1006-1959.2019.19.040]
 LI Ji-wei.The Impact of Two Drug Use Policies on the Use of Essential Drugs in Outpatient Clinics[J].Medical Information,2019,(19):124-126.[doi:10.3969/j.issn.1006-1959.2019.19.040]
点击复制

两种药品使用政策对门诊基本药物使用的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年19期
页码:
124-126
栏目:
调查分析
出版日期:
2019-10-01

文章信息/Info

Title:
The Impact of Two Drug Use Policies on the Use of Essential Drugs in Outpatient Clinics
文章编号:
1006-1959(2019)19-0124-03
作者:
李纪伟
(天津市蓟州区人民医院药剂科,天津 301900)
Author(s):
LI Ji-wei
(Department of Pharmacy,People's Hospital of Jizhou District,Tianjin 301900,China)
关键词:
基本药物用药政策DDDsDDC
Keywords:
Essential drugsMedication policyDDDsDDC
分类号:
R95
DOI:
10.3969/j.issn.1006-1959.2019.19.040
文献标志码:
A
摘要:
目的 分析引进日均费用(DDC)较低的药品及对原药品采取限量措施政策实施前后院、科室两级门诊基本药物使用的变化以及影响。方法 收集2017年5月~2018年8月政策实施前后基本药物在门诊的使用情况资料,比较相同通用名的降压药类基本药物之和与全部降压药的DDDs、各引进的相同通用名的降压药类基本药物的DDDs、各相同通用名的基本药物的平均DDC、各相同通用名的基本药物在门诊使用量最大的两个科室的平均DDC、各相同通用名的基本药物在使用量最大的两个科室间的平均DDC,并进行分析。结果 所引进的药品的DDC低于原药品(P<0.05);引进的相同通用名的降压药类基本药物之和高于全部降压药在政策实施前后门诊使用的DDDs;引进相同通用名的降压药类基本药物使用的DDDs变化比较,政策实施后高于政策实施前(P<0.05);政策实施后各相同通用名的基本药物在门诊使用的平均DDC较政策实施前降低,政策实施后引进的相同通用名的基本药物在门诊使用量最大的两个科室的平均DDC较实施政策前下降(P<0.05);仅氨氯地平、缬沙坦在政策实施前后各时间段各科室间使用量不同(P<0.05)。结论 通过引进DDC较低的基本药物,再加以行政性用药管理,可以增加基本药物在相同药理作用药品中的使用频度、提高各基本药物的使用频度、降低基本药物的平均日费用,但是同时各科室之间药品使用变化是不一致的,需要加强交流,促进基本药物的使用。
Abstract:
Objective To analyze the changes and influences of the use of essential drugs in the outpatient departments of hospitals and departments before and after the introduction of the policies for the introduction of drugs with lower DDC and the adoption of limited measures for the original drugs.Methods For the use of the outpatient clinic before and after the implementation of the policy, compare the sum of the basic drugs of the same generic name with the DDDs of all antihypertensive drugs, the DDDs of the antibiotics of the same common name, and the same common names. The average DDC of the essential drugs, the average DDC of the two drugs with the same common name in the clinic, the average DDC of the two departments with the largest common use in the clinic, and the average DDC of the two drugs with the same common name in the most used, and analyzed.Results The DDC of the introduced drugs was lower than that of the original drugs (P<0.05); the sum of the basic drugs of the same generic name of the antihypertensive drugs introduced was higher than the DDDs used by all antihypertensive drugs in the outpatient clinic before and after the implementation of the policy; The changes of DDDs in the use of essential drugs for antihypertensive drugs were compared. After the implementation of the policy (P<0.05). After the implementation of the policy, the average DDC of the same generic drugs in the clinic was compared. Before the implementation of the policy, the average DDC of the two generic departments with the same generic name introduced after the implementation of the policy was lower than the implementation policy before the implementation of the policy,(P<0.05);Only amlodipine and valsartan were compared between the departments at various time points before and after the implementation of the policy were difference(P<0.05).Conclusion By introducing DDC's lower essential drugs and then administering administrative drugs, it is possible to increase the frequency of use of essential drugs in the same pharmacological drugs, increase the frequency of use of essential drugs, and reduce the average daily cost of essential drugs, but At the same time, changes in drug use between departments are inconsistent, and it is necessary to strengthen communication and promote the use of essential drugs.

参考文献/References:

[1]国务院办公厅.《关于完善国家基本药物制度的意见》政策解读[EB/OL].[2018-09-21].http://www.gov.cn/zhengce/2018-09/21/content_5324368.htm [2]陈超.临床医生诊疗行为的影响因素研究[D].山东大学,2007,5. [3]王珩,赵允伍,李念念,等.安徽省县级医院医生处方基本药物影响因素分析[J].中华医院管理杂志,2016,32(2):151-154. [4]何杏仪,陈丽敏,黄景胜,等.2015-2017年广州中医药大学顺德医院重点监控用药品种应用分析[J].中国医院用药评价与分析,2018,18(4):543-546. [5]韩黎黎,郭小红,徐艳艳,等.肿瘤专科医院推进国家基本药物制度的探索与实践[J].海峡药学,2018,30(3):271-273. [6]陈红英.仿制药一致性评价研究的质量管理[J].中国临床药理学杂志,2018,34(8):993-995.

更新日期/Last Update: 2019-10-01